Review the technical requirements for transitioning short-shelf-life cell therapies away from direct inoculation ...
hVIVO to conduct world's first pivotal Phase III human challenge whooping cough vaccine trial for ILiAD Biotechnologies · World's first pivotal Phase III human challenge trial ("HCT") in Bordetella ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results